Additional Information

Description

Flumazenil 0.1 mg/mL is a medication primarily used to reverse the sedative effects of benzodiazepines in patients. It is administered through intravenous injection and is typically indicated in cases of benzodiazepine overdose or for the reversal of sedation after medical procedures. The medication works by antagonizing the effects of benzodiazepines at their receptor sites in the central nervous system, specifically the gamma-aminobutyric acid (GABA) receptors.

Flumazenil is supplied in a 10 x 10 mL pack, with each vial containing 0.1 mg/mL of flumazenil. The solution is sterile and intended for intravenous use only. Due to the potential for rapid reversal of sedation, it must be administered under close medical supervision, with monitoring of the patient's vital signs and neurological status. The drug is typically used in hospital settings, such as emergency departments or intensive care units.

The medication is contraindicated in patients who have a history of hypersensitivity to flumazenil or any other ingredients in the formulation. It is also not recommended for use in patients with known benzodiazepine dependence or seizures, as it may precipitate withdrawal symptoms or seizures.